ArticleContemporary clinical trials communications2022

Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation.

Atsushi Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.